Uso de talidomida en sangrado recurrente por angiodisplasias gastrointestinales: Caso clínico / Thalidomide for recurrent gastrointestinal bleeding caused by angiodysplasia: Report of one case
Rev. méd. Chile
;
139(7): 909-913, jul. 2011.
Article
in Spanish
| LILACS
| ID: lil-603144
ABSTRACT
Chronic hemodialysis patients may have recurrent bleeding from gastrointestinal angiodysplasia, that often is diffusely located in the digestive tract or in places difficult to reach with traditional endoscopes. Therefore, they cannot be locally treated or removed. We report a 70 years old man on chronic hemodialysis, with severe and persistent anemia due to bleeding from angiodysplasia of the small bowel. Despite administration of high doses of erythropoiesis stimulating agents, intravenous iron, folate, B6 and B12 vitamins, his hemoglobin levels were < 6.5g/dL, becoming totally dependent on transfusions ofred blood cells (up to 46 units per year). Recurrent bleeding was refractory to conventional management and we decided to use thalidomide at doses of 50-100 mg/day achieving rapid control of gastrointestinal bleeding and significant increase of hemoglobin levels, not requiring further transfusions.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Thalidomide
/
Angiodysplasia
/
Angiogenesis Inhibitors
/
Gastrointestinal Hemorrhage
/
Intestines
Type of study:
Etiology study
Limits:
Aged
/
Humans
/
Male
Language:
Spanish
Journal:
Rev. méd. Chile
Journal subject:
Medicine
Year:
2011
Type:
Article
Affiliation country:
Chile
Institution/Affiliation country:
Hospital Naval Almirante Nef/CL
/
Universidad de Valparaíso/CL
Similar
MEDLINE
...
LILACS
LIS